Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:FATE’

Countries with the Smallest Government Per Capita in the World

Hedge Fund and Insider Trading News: Adage Capital Partners, Goosehead Insurance Inc (GSHD), Patrick Industries, Inc. (PATK), Weyland Tech Inc (WEYL), and More

A Hedge Fund Is Doubling Down on Under Armour Stock (Barron’s) Under Armour stock (ticker: UAA) sure didn’t spend 2018 riding the pine. Class......(read more)
James Flynn Deerfield Management

Fate Therapeutics Inc (FATE) Hedge Funds Are Snapping Up

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which......(read more)
Copyright: nexusplexus / 123RF Stock Photo

13G Filing: Redmile Group and Fate Therapeutics Inc (FATE)

Fate Therapeutics Inc (NASDAQ:FATE): Jeremy Green’s Redmile Group filed an amended 13D. You can check out Redmile Group’s latest holdings......(read more)
lab, laboratory, clinic, clinical, scientist, researching, research, chemist, medical, man, male, specialist, focus, chemistry, test, science

Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval

Shares in Fate Therapeutics Inc (NASDAQ:FATE) have soared today, gaining over 10% and reaching as high as $3.18 during the session. Why is Fate Soaring......(read more)
Apple, is AAPL a good stock to buy, two-factor authentication, iMessage, FaceTime, two-step verification,

Here’s Why Traders Are Buzzing About These Five Stocks on Monday

Markets are off to a bullish start this week following a rise in oil prices and fading chances of a Brexit. Investors are also keeping an eye on Federal......(read more)
Biotech Biochemical Stocks Illumina ILMN

Hedge Funds Own Over 25% Of Fate Therapeutics Inc (FATE)

Hedge funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity......(read more)